Get startedLog in
    Picture of Adial Pharmaceuticals logo

    ADIL — Adial Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Adial Pharma Receives Positive Response From FDA Meeting Regarding Vitro Bridging Strategy For AD04

    Picture of Adial Pharmaceuticals logoAdial Pharmaceuticals
    25/02/2025 14:43
    Feb 25 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:

ADIAL PHARMACEUTICALS RECEIVES POSITIVE RESPONSE FROM FDA MEETING REGARDING PROPOSED IN VITRO BRIDGING STRATEGY FOR AD04

ADIAL PHARMACEUTICALS- MOVES FORWARD WITH MANUFACTURING CLINICAL SUPPLIES FOR PHASE 3 PROGRAM IN 2025

Source text: ID:nGNX9ZpY9Q

Further company coverage: ADIL.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Adial Pharmaceuticals

    See all news